The Situation
A major pharmaceuticals company commissioned Anthesis to assess the compliance, financial crime, labour, and human rights risks associated with a Cambodian importer and distributor of pharmaceuticals.
As part of the report, Anthesis provided an overview of the pharmaceutical sector and human rights landscape in Cambodia. The company had a negligible public domain footprint, and the pharmaceuticals sector in Cambodia is known to be high-risk for corruption, with processes for obtaining authorisations and distribution contracts often subject to bribes.
Our Solutions
Despite the high-risk environment, conversations with trusted sources in Cambodia revealed that the company was not known to be involved in corrupt practices or human rights abuses, unlike some other healthcare sector businesses.
Anthesis recommended mitigation strategies to address workplace safety and supply chain oversight to ensure compliance and reduce risks.
Explore our Human Rights services
Discover how Anthesis can support your sustainability ambitions.
Impacts of the Project
The recommendations provided by Anthesis aimed to enhance the company’s operational integrity and safety standards.
By implementing these strategies, the company could improve its reputation, ensure better compliance with human rights standards, and mitigate risks associated with corruption and financial crime in the Cambodian pharmaceutical sector.
Get in touch
We’d love to hear from you
We are the world’s leading purpose driven, digitally enabled, science-based activator. And always welcome inquiries and partnerships to drive positive change together.
Loading…
